Matthew J. Pelo Joins Objective Capital Partners As Vice President

Posted February 11, 2019 by OCP | Post a Comment

Objective Capital Partners is pleased to announce the addition of Matthew Pelo to the OCP team. In his role as Vice President, Matt brings valuable strategic insights and finance expertise to OCP’s clients. His leadership experience and extensive work in the areas of Genomics and Technology make him an outstanding addition to OCP’s senior team and further strengthen OCP’s Life Sciences and Healthcare Practice Group. With a proven ability to achieve exceptional results, Matt further enhances OCP’s ability to deliver premium investment banking and advisory services to our valued clients.

Prior to joining OCP, Matt was a member of the executive team at the New York Genome Center (NYGC) since its formation in 2012 where he played an instrumental role in growing the company into the premier research institution it is today. Matt most recently served as its Vice President Financial Strategy and Operations and had overall responsibility for the execution of research and clinical genomic services.

While with NYGC, Matt additionally held the roles of interim Chief Operating Officer and Chief of Staff to the President and Scientific Director. He led key strategic partnership development activities, including the partnership between NYGC and IBM, partnering with Johnson and Johnson Innovation to build JLabs@NYC, and collaborating with the University of Buffalo and New York State to establish a genomics medicine network throughout New York State. During his tenure with the NYGC, he became the longest serving member on the executive team.

Prior to his work with NYGC, Matt co-founded networkText.com (now Tatango.com), At Tatango, Matt and his team built an industry leading text messaging marketing company, which he successfully exited in 2008.

This article is provided for informational purposes only and does not constitute an offer, invitation or recommendation to buy, sell, subscribe for or issue any securities. While the information provided herein is believed to be accurate and reliable, Objective Capital Partners and BA Securities, LLC makes no representations or warranties, expressed or implied, as to the accuracy or completeness of such information. It should not be construed as investment, legal, or tax advice and may not be reproduced or distributed to any person.

Our Services

Learn about our services and how we can help you sell your business successfully.

LEARN MORE

Contact Us

San Diego Office:
3636 Nobel Dr., Suite 160
San Diego, CA 92122

Los Angeles Office:
10100 Santa Monica Blvd., Suite 300
Los Angeles, CA 90067

Trever Acers
Managing Director
858.663.8662 telephone
trever.acers@objectivecp.com

Channing Hamlet
Managing Director
858.342.4939 telephone
channing.hamlet@objectivecp.com

David H. Crean, Ph.D.
Managing Director
858.461.9490 telephone
david.crean@objectivecp.com

Jack J. Florio
Managing Director
858.864.4339 telephone
jack.florio@objectivecp.com